Renal Impairment Study of Empagliflozin (BI10773) in Japanese Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the effect of the different degrees of renal
impairment on the pharmacokinetics, pharmacodynamics and safety of BI10773 following oral
administration of high dose BI10773 as a single dose in Japanese patients with type 2
diabetes mellitus.